They’ve boosted access to care, and now NPs and PAs are seeing increased practice authority. The changes warrant an industry rethink, two clinician leaders argue.
This list will be updated regularly as industry responds to the death of Floyd and other black victims of police brutality.
For Hollywood scriptwriters, the villain-to-hero arc is a familiar one. The challenges characters must go through in their arc of redemption can help pharmaceutical brands navigate this next year in the spotlight.
Two pharma companies on rethinking drug launches during COVID-19.
A report from CMI/Compas evaluated consumers’ changing habits during the COVID-19 pandemic.
Marketers from GoodRx and Rx Edge Media Network share their insights.
The data is in for 2019, and we break down the ad dollars being spent in different media and also look at the top brands.
Deep content dives. Big listener numbers. Minimal meddling. Eli Lilly, Genentech and Pfizer share the secrets behind their podcast successes.
President Trump wanted to know how quickly pharma could have a vaccine or treatment ready for public use.
Winton previously led corporate communications and public affairs functions at Alkermes and Astellas.
